Gene Symbol | Pearson Correlation Coefficient |
---|---|
KDM2A | 0.936 |
NSD1 | 0.93 |
NCOA6 | 0.929 |
ZNF384 | 0.915 |
TRRAP | 0.913 |
KANSL1 | 0.906 |
EP300 | 0.906 |
FAM193A | 0.901 |
ZCCHC14 | 0.899 |
RNF216 | 0.898 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.626 |
OR4F29 | -0.593 |
RPE65 | -0.297 |
KLRC2 | -0.288 |
NANOGNB | -0.283 |
GSDMC | -0.278 |
CD8B | -0.277 |
ODAM | -0.272 |
KLRF1 | -0.27 |
KLRC3 | -0.268 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB08655 | 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE | Small Molecule | Experimental | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]" | 21443188 |
C524478 | 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole | "1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [CREBBP protein binds to CYP11A1 gene]]" | 18511507 |
C524478 | 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole | "1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [CREBBP protein binds to HSD3B gene]]" | 18511507 |
C524478 | 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole | "1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [TGFB1 protein promotes the reaction [FSHB protein promotes the reaction [ESR1 protein binds to CREBBP protein]]]" | 18511507 |
C524478 | 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole | "1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [FSHB protein promotes the reaction [ESR1 protein binds to CREBBP protein]]" | 18511507 |
C054919 | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | "2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased activity of CREBBP protein" | 22609851 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of CREBBP mRNA | 11705990 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CREBBP mRNA" | 19114083 |
C539142 | 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one | "2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]" | 22850435 |
C539142 | 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one | "KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]]" | 22850435 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of CREBBP mRNA" | 21346803 |
C003898 | 2-anisidine | 2-anisidine results in increased expression of CREBBP mRNA | 28089782 |
C018855 | 2-tert-butylhydroquinone | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]" | 21443188 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein] | 21443188 |
C018855 | 2-tert-butylhydroquinone | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] | 21443188 |
C105509 | (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid | (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid inhibits the reaction [Sodium Oxybate results in increased phosphorylation of CREBBP protein] | 16675135 |
C575894 | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | "3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide inhibits the reaction [[HIF1A protein binds to ARNT protein] binds to [EP300 protein binds to CREBBP protein]]" | 22032632 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]] | 20199942 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | HSPA9 protein promotes the reaction [3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]]] | 20199942 |
C583074 | 4,4'-hexafluorisopropylidene diphenol | "[4,4'-hexafluorisopropylidene diphenol binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CREBBP protein modified form]" | 28751236 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CREBBP mRNA" | 27188386 |
C027576 | 4-hydroxy-2-nonenal | CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA] | 16337876 |
C477187 | 5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole | "5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole results in increased expression of CREBBP mRNA" | 22745752 |
C558243 | 5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid | 5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]] | 21296151 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CREBBP mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CREBBP mRNA | 17562736 |
D000171 | Acrolein | CREBBP protein inhibits the reaction [Acrolein results in decreased expression of BDNF mRNA] | 16337876 |
D000242 | Cyclic AMP | CREBBP protein promotes the reaction [Cyclic AMP results in increased activity of ESR1 protein] | 20360387 |
C430898 | AGN 194204 | AGN 194204 inhibits the reaction [CREBBP protein binds to EGFR promoter] | 21080969 |
C430898 | AGN 194204 | CREBBP affects the susceptibility to AGN 194204 | 21080969 |
C430898 | AGN 194204 | CREBBP protein inhibits the reaction [AGN 194204 results in decreased expression of CDK1 protein] | 21080969 |
C430898 | AGN 194204 | CREBBP protein inhibits the reaction [AGN 194204 results in decreased expression of CDK4 protein] | 21080969 |
C430898 | AGN 194204 | CREBBP protein inhibits the reaction [AGN 194204 results in decreased expression of EGFR protein] | 21080969 |
C430898 | AGN 194204 | CREBBP protein inhibits the reaction [AGN 194204 results in decreased expression of MAPK3 protein] | 21080969 |
C430898 | AGN 194204 | CREBBP protein inhibits the reaction [AGN 194204 results in decreased expression of MYC protein] | 21080969 |
D000450 | Aldosterone | Aldosterone promotes the reaction [NR3C2 protein binds to CREBBP protein] | 19966502 |
D000450 | Aldosterone | Aldosterone results in increased expression of and results in increased localization of CREBBP protein | 19966502 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IL6 protein results in decreased expression of CREBBP protein]" | 15378487 |
D013196 | Dihydrotestosterone | Curcumin inhibits the reaction [Dihydrotestosterone promotes the reaction [CREBBP protein binds to KLK3 enhancer]] | 22258452 |
D013196 | Dihydrotestosterone | Dihydrotestosterone promotes the reaction [CREBBP protein binds to KLK3 enhancer] | 22258452 |
D024502 | alpha-Tocopherol | alpha-Tocopherol deficiency results in increased expression of CREBBP mRNA | 24657723 |
D000602 | Amino Acids, Peptides, and Proteins | "Amino Acids, Peptides, and Proteins inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CREBBP protein]]" | 22003094 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CREBBP mRNA | 16483693 |
D000728 | Androgens | CREBBP protein promotes the reaction [Androgens results in increased activity of AR protein] | 15378487 |
D000735 | Androstenedione | Androstenedione results in increased activity of CREBBP protein | 16467117 |
D000841 | Anisomycin | Anisomycin results in increased expression of CREBBP mRNA | 24247028 |
D000068180 | Aripiprazole | Aripiprazole results in decreased expression of CREBBP mRNA | 17868501 |
D001151 | Arsenic | Arsenic affects the methylation of CREBBP gene | 25304211 |
D001151 | Arsenic | Arsenic results in increased expression of CREBBP mRNA | 28242323 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [CREBBP protein binds to CDKN1A promoter] | 18822310 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[CREBBP protein binds to CDKN1A promoter] which results in increased expression of CDKN1A mRNA] | 18822310 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [CREBBP protein results in increased expression of VCP mRNA] | 18822310 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CREBBP mRNA | 24831965 |
C015001 | arsenite | 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]] | 20199942 |
C015001 | arsenite | arsenite promotes the reaction [RELA protein binds to CREBBP protein] | 20199942 |
C015001 | arsenite | arsenite promotes the reaction [TP53 protein binds to CREBBP protein] | 20199942 |
C015001 | arsenite | HSPA9 protein inhibits the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]] | 20199942 |
C015001 | arsenite | HSPA9 protein promotes the reaction [3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]]] | 20199942 |
C015001 | arsenite | HSPA9 protein promotes the reaction [arsenite promotes the reaction [RELA protein binds to CREBBP protein]] | 20199942 |
C015001 | arsenite | RELA protein inhibits the reaction [arsenite promotes the reaction [TP53 protein binds to CREBBP protein]] | 20199942 |
D001241 | Aspirin | Aspirin results in increased expression of CREBBP mRNA | 11906190 |
D001280 | Atrazine | Atrazine results in decreased expression of CREBBP mRNA | 25929836 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to CREBBP promoter] | 19654925 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CREBBP mRNA" | 19150397 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Valproic Acid results in decreased expression of CREBBP protein] | 27381264 |
D001599 | Berberine | Berberine results in increased expression of CREBBP mRNA | 27311644 |
D004958 | Estradiol | Estradiol affects the expression of CREBBP mRNA | 23557687 |
D004958 | Estradiol | CREBBP mutant form inhibits the reaction [Estradiol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]] | 24771768 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to ESR1 promoter] | 19620290 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to EZH2 promoter] | 25088689 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to HOXB9 promoter] | 27182052 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to HOXC6 promoter] | 25725483 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to IGF1 promoter] | 17872375 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to PTGS2 promoter] | 17872375 |
D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to TTF1 promoter] | 19698761 |
D004958 | Estradiol | Estradiol promotes the reaction [ESR1 protein binds to CREBBP protein binds to BRCA1 protein] | 16417649 |
D004958 | Estradiol | Estradiol promotes the reaction [TNF protein promotes the reaction [CREBBP protein binds to IL6 promoter]] | 24771768 |
D004958 | Estradiol | KMT2D mutant form inhibits the reaction [Estradiol promotes the reaction [CREBBP protein binds to EZH2 promoter]] | 25088689 |
D004958 | Estradiol | Estradiol results in decreased expression of CREBBP mRNA | 20068009 |
D001629 | Bezafibrate | Bezafibrate affects the reaction [PPARA protein binds to CREBBP protein] | 19263263 |
C053541 | bicalutamide | bicalutamide inhibits the reaction [Metribolone results in decreased expression of CREBBP protein] | 15378487 |
C543008 | bis(4-hydroxyphenyl)sulfone | [bis(4-hydroxyphenyl)sulfone binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to CREBBP protein modified form] | 28751236 |
C006780 | bisphenol A | bisphenol A affects the expression of CREBBP mRNA | 23557687 |
C006780 | bisphenol A | [bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to CREBBP protein modified form] | 28751236 |
C006780 | bisphenol A | bisphenol A promotes the reaction [CREBBP protein binds to EZH2 promoter] | 25088689 |
C006780 | bisphenol A | bisphenol A promotes the reaction [CREBBP protein binds to HOTAIR promoter] | 24533973 |
C006780 | bisphenol A | bisphenol A promotes the reaction [CREBBP protein binds to HOXB9 promoter] | 27182052 |
C006780 | bisphenol A | bisphenol A promotes the reaction [CREBBP protein binds to HOXC6 promoter] | 25725483 |
C006780 | bisphenol A | KMT2D mutant form inhibits the reaction [bisphenol A promotes the reaction [CREBBP protein binds to EZH2 promoter]] | 25088689 |
C006780 | bisphenol A | bisphenol A affects the methylation of CREBBP promoter | 27334623 |
C006780 | bisphenol A | bisphenol A affects the expression of CREBBP mRNA | 25181051 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CREBBP mRNA | 24247028 |
D000069286 | Bortezomib | Bortezomib results in decreased expression of CREBBP mRNA | 25913414 |
C018475 | butyraldehyde | butyraldehyde results in decreased expression of CREBBP mRNA | 26079696 |
D020148 | Butyric Acid | Butyric Acid results in increased expression of CREBBP mRNA | 22687346 |
C059041 | calyculin A | calyculin A results in increased phosphorylation of CREBBP protein | 22142222 |
D002166 | Camptothecin | Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein] | 13679428 |
D002166 | Camptothecin | Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein] | 13679428 |
D002166 | Camptothecin | pifithrin inhibits the reaction [Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]] | 13679428 |
D002166 | Camptothecin | pifithrin inhibits the reaction [Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]] | 13679428 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CREBBP mRNA | 18395914 |
D002251 | Carbon Tetrachloride | oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of CREBBP mRNA] | 18395914 |
D002509 | Cephaloridine | Cephaloridine results in decreased expression of CREBBP mRNA | 18500788 |
C084597 | chlorcyclizine | chlorcyclizine results in decreased expression of CREBBP mRNA | 21058326 |
D002737 | Chloroprene | Chloroprene results in decreased expression of CREBBP mRNA | 23125180 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CREBBP gene | 20938992 |
D002857 | Chromium | Chromium affects the reaction [JUN protein binds to CREBBP protein] | 10593907 |
D002857 | Chromium | Chromium inhibits the reaction [RELA protein binds to CREBBP protein] | 10593907 |
C039671 | ciglitazone | ciglitazone inhibits the reaction [CREBBP protein binds to EGFR promoter] | 21080969 |
C039671 | ciglitazone | CREBBP affects the susceptibility to ciglitazone | 21080969 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] | 11278336 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of CDK1 protein] | 21080969 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of CDK4 protein] | 21080969 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of EGFR protein] | 21080969 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of MAPK3 protein] | 21080969 |
C039671 | ciglitazone | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of MYC protein] | 21080969 |
D002994 | Clofibrate | Clofibrate inhibits the reaction [CREBBP protein binds to EGFR promoter] | 21080969 |
D002994 | Clofibrate | CREBBP affects the susceptibility to Clofibrate | 21080969 |
D002994 | Clofibrate | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of CDK1 protein] | 21080969 |
D002994 | Clofibrate | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of CDK4 protein] | 21080969 |
D002994 | Clofibrate | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of EGFR protein] | 21080969 |
D002994 | Clofibrate | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of MAPK3 protein] | 21080969 |
D002994 | Clofibrate | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of MYC protein] | 21080969 |
C018021 | cobaltous chloride | [cobaltous chloride results in increased activity of SRC protein] promotes the reaction [[[HIF1A protein binds to STAT3 protein modified form] which binds to VEGFA promoter] binds to [APEX1 protein binds to CREBBP promoter]] | 15735682 |
D003042 | Cocaine | Cocaine results in increased expression of CREBBP mRNA | 17898221 |
D005576 | Colforsin | Colforsin promotes the reaction [GCM1 protein binds to CREBBP protein] | 16166624 |
D005576 | Colforsin | CREBBP protein affects the reaction [Colforsin results in increased activity of GCM1 protein] | 16166624 |
D003300 | Copper | Copper results in decreased expression of CREBBP mRNA | 22465980 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of CREBBP mRNA | 19549813 |
D003345 | Corticosterone | "2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]" | 22850435 |
D003345 | Corticosterone | Corticosterone results in decreased expression of CREBBP protein | 22850435 |
D003345 | Corticosterone | "KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]]" | 22850435 |
D003474 | Curcumin | Curcumin inhibits the reaction [Dihydrotestosterone promotes the reaction [CREBBP protein binds to KLK3 enhancer]] | 22258452 |
D003474 | Curcumin | Curcumin results in decreased expression of CREBBP | 18462866 |
D017373 | Cyproterone Acetate | [Cyproterone Acetate binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CREBBP protein modified form] | 28751236 |
D017373 | Cyproterone Acetate | [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer] | 15308689 |
D017373 | Cyproterone Acetate | [Cyproterone Acetate binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter] | 15308689 |
D003634 | DDT | DDT results in increased activity of CREBBP protein | 22609851 |
C014347 | decitabine | decitabine results in decreased expression of CREBBP mRNA | 27915011 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CREBBP mRNA | 24247028 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CREBBP mRNA | 21266533 |
D003994 | Bucladesine | Bucladesine promotes the reaction [CREBBP protein binds to SOD2 promoter] | 20685861 |
D003994 | Bucladesine | [Bucladesine promotes the reaction [CREB1 protein modified form binds to STAR promoter]] promotes the reaction [CREBBP protein binds to STAR promoter] | 19282384 |
D003994 | Bucladesine | CREBBP protein promotes the reaction [CREB1 protein promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of STAR mRNA]]] | 19282384 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of CREBBP mRNA | 27392435 |
D002945 | Cisplatin | [Cisplatin co-treated with Quercetin] results in increased expression of CREBBP mRNA | 27514524 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CREBBP mRNA | 27594783 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CREBBP protein | 17498666 |
D003632 | Dichlorodiphenyldichloroethane | Dichlorodiphenyldichloroethane results in increased activity of CREBBP protein | 22609851 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of CREBBP protein | 22609851|2758988 |
C000944 | dicrotophos | dicrotophos results in increased expression of CREBBP mRNA | 28302478 |
C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of CREBBP mRNA | 26924002 |
D004054 | Diethylstilbestrol | Diethylstilbestrol promotes the reaction [CREBBP protein binds to EZH2 promoter] | 25088689 |
D004054 | Diethylstilbestrol | Diethylstilbestrol promotes the reaction [CREBBP protein binds to HOTAIR promoter] | 24533973 |
D004054 | Diethylstilbestrol | KMT2D mutant form inhibits the reaction [Diethylstilbestrol promotes the reaction [CREBBP protein binds to EZH2 promoter]] | 25088689 |
D002117 | Calcitriol | Calcitriol affects the localization of CREBBP protein | 15647825 |
D002117 | Calcitriol | Calcitriol promotes the reaction [CREBBP protein binds to CYP24A1 promoter] | 15647825 |
D002117 | Calcitriol | Calcitriol promotes the reaction [CREBBP protein binds to SPP1 promoter] | 15647825 |
C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of CREBBP mRNA | 26924002 |
C051904 | dinophysistoxin 1 | dinophysistoxin 1 results in increased expression of CREBBP mRNA | 28939011 |
D004237 | Diuron | Diuron results in decreased expression of CREBBP mRNA | 21551480 |
D004317 | Doxorubicin | Doxorubicin promotes the reaction [CREBBP protein binds to ESR1 promoter] | 19351845 |
D004317 | Doxorubicin | Doxorubicin promotes the reaction [TP53 protein binds to CREBBP protein] | 19351845 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of CREBBP protein | 17498666 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of CREBBP mRNA | 28865727 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal promotes the reaction [CREBBP protein binds to KRT19 promoter]" | 17095596 |
D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] | 21443188 |
C044101 | endotoxin, Escherichia coli | "endotoxin, Escherichia coli results in decreased expression of CREBBP mRNA" | 15919760 |
D000431 | Ethanol | Ethanol results in decreased expression of CREBBP mRNA | 20655511 |
D000431 | Ethanol | "N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of CREBBP mRNA]" | 20655511 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in decreased expression of CREBBP mRNA | 22213190 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CREBBP gene | 20938992 |
D005557 | Formaldehyde | Formaldehyde results in decreased expression of CREBBP mRNA | 20655997 |
C069837 | fullerene C60 | fullerene C60 results in decreased expression of CREBBP mRNA | 19167457 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [CREBBP protein binds to CYP11A1 gene]] | 18511507 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [CREBBP protein binds to HSD3B gene]] | 18511507 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [TGFB1 protein promotes the reaction [FSHB protein promotes the reaction [ESR1 protein binds to CREBBP protein]]] | 18511507 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [[TNF protein co-treated with resveratrol] promotes the reaction [CREBBP protein binds to IL6 promoter]] | 24771768 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [FSHB protein promotes the reaction [ESR1 protein binds to CREBBP protein]] | 18511507 |
D005839 | Gentamicins | Gentamicins results in increased expression of CREBBP mRNA | 22061828 |
D005947 | Glucose | [INS protein co-treated with Glucose] results in increased expression of CREBBP mRNA | 22634610 |
D019307 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of CREBBP mRNA | 24349266 |
D012978 | Sodium Oxybate | (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid inhibits the reaction [Sodium Oxybate results in increased phosphorylation of CREBBP protein] | 16675135 |
D012978 | Sodium Oxybate | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sodium Oxybate results in increased phosphorylation of CREBBP protein] | 16675135 |
D012978 | Sodium Oxybate | Sodium Oxybate results in increased phosphorylation of CREBBP protein | 16675135 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CREBBP mRNA | 25613284 |
C051890 | irinotecan | irinotecan analog results in decreased expression of CREBBP mRNA | 18927307 |
C051890 | irinotecan | irinotecan metabolite results in decreased expression of CREBBP mRNA | 15956246 |
C051890 | irinotecan | irinotecan results in decreased expression of CREBBP mRNA | 15956246 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of CREBBP mRNA | 27392435 |
C073601 | KT 5823 | "KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]]" | 22850435 |
C045463 | leflunomide | leflunomide results in increased expression of CREBBP mRNA | 24136188 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CREBBP mRNA" | 24972896 |
D008070 | Lipopolysaccharides | "Amino Acids, Peptides, and Proteins inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CREBBP protein]]" | 22003094 |
D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [RELA protein binds to CREBBP protein] | 22003094 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of CREBBP mRNA | 15919760|1684731 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CREBBP mRNA | 26378955 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate promotes the reaction [CREBBP protein binds to SOD2 promoter] | 20685861 |
D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of CREBBP mRNA | 20353558 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CREBBP gene | 20938992 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CREBBP mRNA | 23103053 |
C004925 | methylmercuric chloride | methylmercuric chloride affects the expression of CREBBP mRNA | 20864626 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CREBBP mRNA" | 26251327 |
D015741 | Metribolone | bicalutamide inhibits the reaction [Metribolone results in decreased expression of CREBBP protein] | 15378487 |
D015741 | Metribolone | [Metribolone binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to CREBBP protein modified form] | 28751236 |
D015741 | Metribolone | Metribolone inhibits the reaction [CREBBP protein results in increased activity of AR protein] | 11981028 |
D015741 | Metribolone | Metribolone results in decreased expression of CREBBP mRNA | 15378487 |
D015741 | Metribolone | Metribolone results in decreased expression of CREBBP protein | 15378487 |
C517398 | MF101 extract | MF101 extract promotes the reaction [CREBBP protein binds to KRT19 promoter] | 17095596 |
D015735 | Mifepristone | [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 enhancer] | 15308689 |
D015735 | Mifepristone | [Mifepristone binds to AR protein] promotes the reaction [CREBBP protein binds to KLK3 promoter] | 15308689 |
C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of CREBBP mRNA | 26924002 |
C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sodium Oxybate results in increased phosphorylation of CREBBP protein] | 16675135 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CREBBP mRNA" | 25554681 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of CREBBP mRNA | 19167457 |
D009534 | Niclosamide | Niclosamide results in increased expression of CREBBP mRNA | 22576131 |
C520612 | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid | "N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of CREBBP mRNA]" | 20655511 |
C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [HIF1A protein binds to CREBBP protein]" | 16579968 |
D019787 | Linoleic Acid | Linoleic Acid affects the reaction [PPARA protein binds to CREBBP protein] | 19263263 |
D019301 | Oleic Acid | Oleic Acid results in decreased expression of CREBBP mRNA | 24349266 |
D019319 | Okadaic Acid | Okadaic Acid results in increased expression of CREBBP mRNA | 28939011 |
D019319 | Okadaic Acid | Okadaic Acid results in increased phosphorylation of CREBBP protein | 16059639 |
C016340 | o,p'-DDT | "o,p'-DDT promotes the reaction [MAP2K6 protein results in increased activity of CREBBP protein]" | 22609851 |
C016340 | o,p'-DDT | "o,p'-DDT results in increased activity of CREBBP protein" | 22609851 |
C016340 | o,p'-DDT | "SB 203580 inhibits the reaction [o,p'-DDT results in increased activity of CREBBP protein]" | 22609851 |
D008939 | Mitotane | Mitotane results in increased activity of CREBBP protein | 22609851 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of CREBBP mRNA | 25729387 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CREBBP mRNA | 22629407 |
D010100 | Oxygen | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CREBBP mRNA] | 22629407 |
C037573 | oxymatrine | oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of CREBBP mRNA] | 18395914 |
D010269 | Paraquat | Paraquat results in decreased expression of CREBBP mRNA | 28619522 |
D010269 | Paraquat | Paraquat results in increased expression of CREBBP protein | 20478973 |
C551803 | PCI 32765 | CREBBP protein mutant form results in decreased susceptibility to PCI 32765 | 26254443 |
D010634 | Phenobarbital | Phenobarbital affects the expression of CREBBP mRNA | 19159669 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of CREBBP mRNA | 23091169 |
D010656 | Phenylephrine | CREBBP protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | 11705990 |
D010656 | Phenylephrine | CREBBP protein results in increased susceptibility to Phenylephrine | 12477714 |
D010656 | Phenylephrine | Phenylephrine promotes the reaction [CREB1 protein binds to CREBBP protein] | 15522277 |
D010656 | Phenylephrine | Phenylephrine promotes the reaction [NR3C2 protein binds to CREBBP protein] | 19966502 |
D010656 | Phenylephrine | [Phenylephrine results in increased activity of CREBBP protein] which results in increased expression of NPPA protein | 12477714 |
D010656 | Phenylephrine | Phenylephrine results in increased expression of and results in increased localization of CREBBP protein | 19966502 |
D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of and results in increased activity of CREBBP protein | 15006641 |
D010656 | Phenylephrine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
D010656 | Phenylephrine | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
D010656 | Phenylephrine | MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
D010656 | Phenylephrine | Phenylephrine results in increased expression of CREBBP mRNA | 11705990 |
D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
D010695 | Phlorhizin | Phlorhizin results in decreased expression of CREBBP mRNA | 22538082 |
C121565 | pifithrin | pifithrin inhibits the reaction [Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]] | 13679428 |
C121565 | pifithrin | pifithrin inhibits the reaction [Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]] | 13679428 |
C121565 | pifithrin | pifithrin promotes the reaction [RELA protein binds to CREBBP protein] | 13679428 |
C006253 | pirinixic acid | pirinixic acid affects the reaction [PPARA protein binds to CREBBP protein] | 19263263 |
D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased expression of CREBBP mRNA] | 11705990 |
C045950 | propiconazole | propiconazole results in decreased expression of CREBBP mRNA | 21278054 |
C005556 | propionaldehyde | propionaldehyde results in decreased expression of CREBBP mRNA | 26079696 |
D011794 | Quercetin | [Cisplatin co-treated with Quercetin] results in increased expression of CREBBP mRNA | 27514524 |
D011794 | Quercetin | Quercetin results in decreased expression of CREBBP protein | 15580028 |
D011794 | Quercetin | Quercetin results in increased expression of CREBBP mRNA | 14715546 |
D011794 | Quercetin | Quercetin inhibits the reaction [CREBBP protein binds to CXCL10 promoter] | 21857970 |
D011794 | Quercetin | Quercetin inhibits the reaction [CREBBP protein binds to CXCL2 promoter] | 21857970 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein promotes the reaction [CREBBP protein binds to CXCL10 promoter]] | 17449583 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein promotes the reaction [CREBBP protein binds to CXCL2 promoter]] | 17449583 |
D011794 | Quercetin | Quercetin affects the activity of CREBBP modified form | 19423323 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride promotes the reaction [CREBBP protein binds to IGF1 promoter] | 17872375 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride promotes the reaction [CREBBP protein binds to PTGS2 promoter] | 17872375 |
C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]] | 19631782 |
C059514 | resveratrol | CREBBP mutant form inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]] | 24771768 |
C059514 | resveratrol | fulvestrant inhibits the reaction [[TNF protein co-treated with resveratrol] promotes the reaction [CREBBP protein binds to IL6 promoter]] | 24771768 |
C059514 | resveratrol | resveratrol promotes the reaction [PML protein binds to CREBBP protein] | 19631782 |
C059514 | resveratrol | resveratrol promotes the reaction [TNF protein promotes the reaction [CREBBP protein binds to IL6 promoter]] | 24771768 |
C059514 | resveratrol | resveratrol promotes the reaction [TP53 protein binds to PML protein binds to CREBBP protein] | 19631782 |
C059514 | resveratrol | resveratrol results in increased expression of CREBBP mRNA | 15149879 |
C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to RELA protein]] | 16474181 |
C059514 | resveratrol | resveratrol inhibits the reaction [CREBBP protein results in increased acetylation of FOXO1 protein] | 19740748 |
C089730 | rosiglitazone | 5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]] | 21296151 |
C089730 | rosiglitazone | rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein] | 21296151 |
D012402 | Rotenone | Rotenone results in increased expression of CREBBP mRNA | 21536665 |
C093642 | SB 203580 | "SB 203580 inhibits the reaction [o,p'-DDT results in increased activity of CREBBP protein]" | 22609851 |
D012643 | Selenium | Selenium results in decreased expression of CREBBP mRNA | 19244175 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CREBBP mRNA | 12377979 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CREBBP mRNA | 19822182 |
D012999 | Soman | Soman results in decreased expression of CREBBP mRNA | 19281266 |
D013311 | Streptozocin | Streptozocin results in decreased expression of CREBBP mRNA | 25905778 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CREBBP mRNA | 26378955 |
D013739 | Testosterone | Testosterone results in increased expression of CREBBP mRNA | 21880219 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [CREBBP protein binds to CYP1A1 promoter] | 15964790 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CREBBP mRNA | 21570461|2405805 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CREBBP promoter] | 19654925 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CREBBP mRNA | 19465110 |
D013755 | Tetradecanoylphorbol Acetate | CREBBP protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] | 11278336 |
D013755 | Tetradecanoylphorbol Acetate | CREBBP protein promotes the reaction [CREB1 protein promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of STAR mRNA]]] | 19282384 |
D013755 | Tetradecanoylphorbol Acetate | PRKD1 protein promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to STAR promoter]] | 21047949 |
D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to RELA protein]] | 16474181 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate promotes the reaction [CREB1 protein modified form binds to STAR promoter]] promotes the reaction [CREBBP protein binds to STAR promoter] | 19282384 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to RELA protein] | 16474181 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [CREBBP protein binds to STAR promoter] | 21047949 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CREBBP mRNA | 25613284 |
D019284 | Thapsigargin | Thapsigargin results in increased expression of CREBBP mRNA | 24247028 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of CREBBP mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in decreased expression of CREBBP mRNA | 25729387 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [[CREBBP protein binds to MAPK3 promoter] which affects the expression of MAPK3 mRNA] | 16050810 |
D014212 | Tretinoin | Tretinoin promotes the reaction [CREBBP protein binds to HAS2 promoter] | 17307735 |
D014212 | Tretinoin | Tretinoin promotes the reaction [CREBBP protein binds to PDK4 promoter] | 16757381 |
D014212 | Tretinoin | Tretinoin promotes the reaction [CREBBP protein binds to RARA protein] | 16417649 |
D014212 | Tretinoin | Tretinoin results in increased expression of CREBBP mRNA | 28053092 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [CREBBP protein binds to RETN promoter] | 15047602 |
C012589 | trichostatin A | trichostatin A promotes the reaction [CREBBP protein binds to PDK4 promoter] | 16757381 |
C057693 | troglitazone | RXRA protein inhibits the reaction [CREBBP protein results in increased susceptibility to troglitazone] | 15581905 |
C057693 | troglitazone | troglitazone results in decreased expression of CREBBP mRNA | 28973697 |
C057693 | troglitazone | CREBBP protein results in increased susceptibility to troglitazone | 15581905 |
D014520 | Urethane | Urethane results in increased expression of CREBBP mRNA | 28818685 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in decreased expression of CREBBP mRNA | 19493473 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CREBBP mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CREBBP mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CREBBP mRNA | 19101580|2208335 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of CREBBP gene | 28853863 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of CREBBP gene | 29154799 |
D014635 | Valproic Acid | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Valproic Acid results in decreased expression of CREBBP protein] | 27381264 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CREBBP mRNA | 19136453|2738126 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CREBBP protein | 27381264 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CREBBP gene | 25560391 |
D014750 | Vincristine | Vincristine results in increased expression of CREBBP mRNA | 23649840 |
D014810 | Vitamin E | Vitamin E results in decreased expression of CREBBP mRNA | 19244175 |
C111237 | vorinostat | vorinostat promotes the reaction [PML protein binds to CREBBP protein] | 19631782 |
C111237 | vorinostat | vorinostat promotes the reaction [TP53 protein binds to PML protein binds to CREBBP protein] | 19631782 |
D015032 | Zinc | Zinc promotes the reaction [MTF1 protein binds to EP300 protein binds to CREBBP protein] | 18458062 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000987 | proximal promoter sequence-specific DNA binding | - | IDA | 21539536 |
GO:0001078 | transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | - | IDA | 21539536 |
GO:0001085 | RNA polymerase II transcription factor binding | - | IPI | 21539536 |
GO:0001102 | RNA polymerase II activating transcription factor binding | - | TAS | 11001584 |
GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding | - | IDA | 21539536 |
GO:0002039 | p53 binding | - | IPI | 9194565 |
GO:0003682 | chromatin binding | - | IDA | 24939902 |
GO:0003684 | damaged DNA binding | - | IDA | 24939902 |
GO:0003700 | DNA-binding transcription factor activity | - | TAS | 7913207 |
GO:0003713 | transcription coactivator activity | - | IDA | 12169688 12435739 12586840 12929931 14645221 |
GO:0003713 | transcription coactivator activity | - | IPI | 8684459 |
GO:0003713 | transcription coactivator activity | - | TAS | 10362258 11001584 |
GO:0004402 | histone acetyltransferase activity | - | IDA | 11742995 |
GO:0004402 | histone acetyltransferase activity | - | TAS | 10362258 |
GO:0005515 | protein binding | - | IPI | 8684459 9018065 9194564 9323138 9687513 9811832 9887100 10049825 10196247 10347196 10428834 10487758 10722728 10722738 10823891 10866662 11113179 11438528 11568182 11799127 11897665 11940655 11971985 12435739 12482968 14645221 14716005 15075319 15126506 15220471 15273251 15674325 16043483 16154084 16291753 16611888 16799563 17075044 17362989 17382325 17476304 17500595 17923090 18309294 18316612 18836453 19234109 19805293 20541699 20541704 20581830 21602890 21670263 21751375 21903422 23273993 23434580 23441852 23746807 24361270 24939902 25241761 25314079 25609649 |
GO:0008134 | transcription factor binding | - | IPI | 15509593 |
GO:0008270 | zinc ion binding | - | IEA | - |
GO:0016407 | acetyltransferase activity | - | EXP | 12456660 16135789 |
GO:0016407 | acetyltransferase activity | - | IDA | 11742995 15273251 24939902 |
GO:0034212 | peptide N-acetyltransferase activity | - | TAS | - |
GO:0043426 | MRF binding | - | IDA | 8621548 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | - | IDA | 21539536 |
GO:0001666 | response to hypoxia | - | TAS | 15261140 |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | - | TAS | - |
GO:0006355 | regulation of transcription, DNA-templated | - | IDA | 12169688 |
GO:0006355 | regulation of transcription, DNA-templated | - | TAS | 15261140 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | - | TAS | - |
GO:0006473 | protein acetylation | - | IDA | 15273251 24939902 |
GO:0006473 | protein acetylation | - | TAS | 28386764 |
GO:0007165 | signal transduction | - | NAS | 15261140 |
GO:0007219 | Notch signaling pathway | - | TAS | - |
GO:0007221 | positive regulation of transcription of Notch receptor target | - | TAS | - |
GO:0008589 | regulation of smoothened signaling pathway | - | TAS | 11001584 |
GO:0016032 | viral process | - | IEA | - |
GO:0016573 | histone acetylation | - | IDA | 11742995 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | - | IDA | 12435739 |
GO:0019216 | regulation of lipid metabolic process | - | TAS | - |
GO:0031648 | protein destabilization | - | IMP | 24939902 |
GO:0032481 | positive regulation of type I interferon production | - | TAS | - |
GO:0034644 | cellular response to UV | - | IDA | 24939902 |
GO:0042592 | homeostatic process | - | NAS | 15261140 |
GO:0042733 | embryonic digit morphogenesis | - | TAS | 11001584 |
GO:0042981 | regulation of apoptotic process | - | TAS | - |
GO:0045637 | regulation of myeloid cell differentiation | - | TAS | - |
GO:0045747 | positive regulation of Notch signaling pathway | - | TAS | - |
GO:0045893 | positive regulation of transcription, DNA-templated | - | IDA | 11742995 |
GO:0045893 | positive regulation of transcription, DNA-templated | - | ISS | - |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | TAS | - |
GO:0048511 | rhythmic process | - | IEA | - |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | - | TAS | - |
GO:0065003 | protein-containing complex assembly | - | TAS | 7913207 |
GO:1900034 | regulation of cellular response to heat | - | TAS | - |
GO:1904837 | beta-catenin-TCF complex assembly | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000123 | histone acetyltransferase complex | - | IEA | - |
GO:0000790 | nuclear chromatin | - | IDA | 21539536 |
GO:0005634 | nucleus | - | IC | 12169688 |
GO:0005634 | nucleus | - | IDA | 12929931 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005737 | cytoplasm | - | IDA | 12929931 |
GO:0016604 | nuclear body | - | IDA | 15488321 |
KEGG ID | KEGG Term |
---|---|
hsa04110 | Cell cycle |
hsa04310 | Wnt signaling pathway |
hsa04330 | Notch signaling pathway |
hsa04350 | TGF-beta signaling pathway |
hsa04520 | Adherens junction |
hsa04630 | Jak-STAT signaling pathway |
hsa04720 | Long-term potentiation |
hsa04916 | Melanogenesis |
hsa05016 | Huntington's disease |
hsa05200 | Pathways in cancer |
hsa05211 | Renal cell carcinoma |
hsa05215 | Prostate cancer |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109582 | Hemostasis | TAS |
R-HSA-1234158 | Regulation of gene expression by Hypoxia-inducible Factor | TAS |
R-HSA-1234174 | Regulation of Hypoxia-inducible Factor (HIF) by oxygen | TAS |
R-HSA-1266738 | Developmental Biology | TAS |
R-HSA-1266738 | Developmental Biology | IEA |
R-HSA-1368082 | RORA activates gene expression | TAS |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian gene expression | IEA |
R-HSA-1430728 | Metabolism | TAS |
R-HSA-1430728 | Metabolism | IEA |
R-HSA-157118 | Signaling by NOTCH | IEA |
R-HSA-157118 | Signaling by NOTCH | TAS |
R-HSA-1592230 | Mitochondrial biogenesis | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | TAS |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | TAS |
R-HSA-1852241 | Organelle biogenesis and maintenance | TAS |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | IEA |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | TAS |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | IEA |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | TAS |
R-HSA-195721 | Signaling by WNT | TAS |
R-HSA-1980143 | Signaling by NOTCH1 | IEA |
R-HSA-1980143 | Signaling by NOTCH1 | TAS |
R-HSA-1989781 | PPARA activates gene expression | TAS |
R-HSA-1989781 | PPARA activates gene expression | IEA |
R-HSA-201681 | TCF dependent signaling in response to WNT | TAS |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | TAS |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | IEA |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | TAS |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-212436 | Generic Transcription Pathway | IEA |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | TAS |
R-HSA-2262749 | Cellular response to hypoxia | TAS |
R-HSA-2262752 | Cellular responses to stress | TAS |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | TAS |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | TAS |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | TAS |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | TAS |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | TAS |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | TAS |
R-HSA-3134973 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | TAS |
R-HSA-3214847 | HATs acetylate histones | IEA |
R-HSA-3247509 | Chromatin modifying enzymes | IEA |
R-HSA-3371556 | Cellular response to heat stress | TAS |
R-HSA-3371568 | Attenuation phase | TAS |
R-HSA-3371571 | HSF1-dependent transactivation | TAS |
R-HSA-350054 | Notch-HLH transcription pathway | TAS |
R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | TAS |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | IEA |
R-HSA-400206 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | TAS |
R-HSA-400206 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | IEA |
R-HSA-400253 | Circadian Clock | TAS |
R-HSA-400253 | Circadian Clock | IEA |
R-HSA-4839726 | Chromatin organization | IEA |
R-HSA-556833 | Metabolism of lipids | TAS |
R-HSA-556833 | Metabolism of lipids | IEA |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | IEA |
R-HSA-5619507 | Activation of HOX genes during differentiation | IEA |
R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | TAS |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | TAS |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | IEA |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-74160 | Gene expression (Transcription) | IEA |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | TAS |
R-HSA-8866907 | Activation of the TFAP2 (AP-2) family of transcription factors | TAS |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | IEA |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | TAS |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | TAS |
R-HSA-8939211 | ESR-mediated signaling | TAS |
R-HSA-8939246 | RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | TAS |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | IEA |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | TAS |
R-HSA-8953897 | Cellular responses to external stimuli | TAS |
R-HSA-8957322 | Metabolism of steroids | TAS |
R-HSA-9006931 | Signaling by Nuclear Receptors | TAS |
R-HSA-9012852 | Signaling by NOTCH3 | TAS |
R-HSA-9012852 | Signaling by NOTCH3 | IEA |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | TAS |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | IEA |
R-HSA-9018519 | Estrogen-dependent gene expression | TAS |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | TAS |
R-HSA-933541 | TRAF6 mediated IRF7 activation | TAS |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
25839328 | Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. (2015 Apr 2) | Zhang L | Am J Hum Genet |
26873401 | Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. (2016 May) | Sawada G | Gastroenterology |